vs
Side-by-side financial comparison of Arbutus Biopharma Corp (ABUS) and SharpLink Gaming, Inc. (SBET). Click either name above to swap in a different company.
SharpLink Gaming, Inc. is the larger business by last-quarter revenue ($10.8M vs $10.7M, roughly 1.0× Arbutus Biopharma Corp). SharpLink Gaming, Inc. runs the higher net margin — 961.6% vs 23.5%, a 938.1% gap on every dollar of revenue. On growth, SharpLink Gaming, Inc. posted the faster year-over-year revenue change (1129.9% vs 522.2%).
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
Bonne Terre Limited is a British-based gambling company, owned by Flutter Entertainment, with headquarters in Leeds, West Yorkshire and offices in Solihull. Sky Betting & Gaming consists of five core brands: Sky Bet, Sky Vegas, Sky Casino, Sky Poker and Sky Bingo.
ABUS vs SBET — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.7M | $10.8M |
| Net Profit | $2.5M | $104.3M |
| Gross Margin | — | — |
| Operating Margin | 13.9% | — |
| Net Margin | 23.5% | 961.6% |
| Revenue YoY | 522.2% | 1129.9% |
| Net Profit YoY | 112.7% | 11880.2% |
| EPS (diluted) | $0.01 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $10.8M | ||
| Q2 25 | $10.7M | $697.3K | ||
| Q1 25 | — | $741.7K | ||
| Q4 24 | — | $823.1K | ||
| Q3 24 | — | $881.7K | ||
| Q2 24 | — | $981.3K | ||
| Q1 24 | — | $975.9K | ||
| Q4 23 | $2.1M | — |
| Q3 25 | — | $104.3M | ||
| Q2 25 | $2.5M | $-103.4M | ||
| Q1 25 | — | $-974.9K | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-885.1K | ||
| Q2 24 | — | $-463.0K | ||
| Q1 24 | — | $12.4M | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | 30.0% | ||
| Q1 25 | — | 17.8% | ||
| Q4 24 | — | 20.2% | ||
| Q3 24 | — | 19.6% | ||
| Q2 24 | — | 28.5% | ||
| Q1 24 | — | 29.4% | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | 13.9% | -14826.0% | ||
| Q1 25 | — | -124.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -90.4% | ||
| Q2 24 | — | -122.8% | ||
| Q1 24 | — | -172.6% | ||
| Q4 23 | -967.2% | — |
| Q3 25 | — | 961.6% | ||
| Q2 25 | 23.5% | -14832.1% | ||
| Q1 25 | — | -131.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -100.4% | ||
| Q2 24 | — | -47.2% | ||
| Q1 24 | — | 1265.5% | ||
| Q4 23 | — | — |
| Q3 25 | — | $0.62 | ||
| Q2 25 | $0.01 | $-4.27 | ||
| Q1 25 | — | $-1.84 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-3.02 | ||
| Q2 24 | — | $-1.35 | ||
| Q1 24 | — | $40.31 | ||
| Q4 23 | $-0.12 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | — |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $83.0M | $3.1B |
| Total Assets | $103.3M | $3.1B |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | $37.4M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | $126.0M | — |
| Q3 25 | — | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | — | ||
| Q4 23 | $0 | — |
| Q3 25 | — | $3.1B | ||
| Q2 25 | $83.0M | $452.5M | ||
| Q1 25 | — | $2.1M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $2.0M | ||
| Q2 24 | — | $2.8M | ||
| Q1 24 | — | $2.9M | ||
| Q4 23 | $106.0M | — |
| Q3 25 | — | $3.1B | ||
| Q2 25 | $103.3M | $453.9M | ||
| Q1 25 | — | $2.8M | ||
| Q4 24 | — | $2.6M | ||
| Q3 24 | — | $2.9M | ||
| Q2 24 | — | $3.8M | ||
| Q1 24 | — | $5.4M | ||
| Q4 23 | $144.4M | — |
| Q3 25 | — | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | — | ||
| Q4 23 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $-6.3M |
| Free Cash FlowOCF − Capex | — | $-6.3M |
| FCF MarginFCF / Revenue | — | -57.9% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | -6.24× | -0.06× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-6.3M | ||
| Q2 25 | $-15.7M | $-1.6M | ||
| Q1 25 | — | $-514.1K | ||
| Q4 24 | — | $-22.8M | ||
| Q3 24 | — | $-591.2K | ||
| Q2 24 | — | $-1.7M | ||
| Q1 24 | — | $-19.3M | ||
| Q4 23 | $-17.3M | — |
| Q3 25 | — | $-6.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-22.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-19.3M | ||
| Q4 23 | — | — |
| Q3 25 | — | -57.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2772.0% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -1977.2% | ||
| Q4 23 | — | — |
| Q3 25 | — | 0.0% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.2% | ||
| Q4 23 | 0.0% | — |
| Q3 25 | — | -0.06× | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -1.56× | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABUS
Segment breakdown not available.
SBET
| ETH Staking Segmet | $10.3M | 95% |
| Other | $569.8K | 5% |
